Japan’s Takeda Pharmaceutical Co said on Thursday it would import and distribute 50 million doses of Moderna Inc’s COVID-19 vaccine candidate in the country.
The supply would start in the first half of 2021, pending the grant of licence in Japan, Takeda said in a release. The companies had previously been in talks to supply 40 million or more doses of the vaccine candidate in Japan.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
